Orphinic Scientific sources promising projects globally, focusing on the biotech ecosystem in Poland and Central and Eastern Europe, leveraging a network of universities and accelerators.

The company invests in single-product companies, manages clinical trials, and provides capital for clinical phases, aiming for quick project termination if hypotheses are unsupported.